Medusa Medical Technologies by ESO | Medusa achieves FDA 510(k)
post-template-default,single,single-post,postid-296,single-format-standard,ajax_updown_fade,page_not_loaded,smooth_scroll,boxed,,qode-theme-ver-2.4,wpb-js-composer js-comp-ver-7.7.1,vc_responsive

Medusa achieves FDA 510(k)

Medusa achieves FDA 510(k)

20:19 26 January in Siren ePCR Suite

Medusa Medical is pleased to announce that it has achieved FDA 510(k) premarket notification clearance (K131272) from the US Food and Drug Administration for Siren ePCR Suite.

No Comments

Post A Comment